Concepedia

Dimitris Karagiannis

DK

Statistics

Publications

7

Citations

490

H-Index

7

Active since

2017

Affiliations

Columbia University Irving Medical Center(Current)

Stanford University

Columbia University

Massachusetts Institute of Technology

New York University

Dimitris Karagiannis is an author at Columbia University Irving Medical Center specializing in molecular oncology, epigenetics, and cancer epigenetics.

ORCID

Publications per year

2017–2025

7

Publications

7

Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer

Volkan I. Sayin, Sarah E. LeBoeuf, Simranjit X. Singh et al. · eLife · 2017 · 231 citations · Full text

, , +17

The lysine‐specific methyltransferase KMT2C/MLL3 regulates DNA repair components in cancer

Dimitris Karagiannis, Margaritis Avgeris, Alexander Polyzos et al. · EMBO Reports · 2019 · 132 citations · Full text

, , +14

Histone methylation antagonism drives tumor immune evasion in squamous cell carcinomas

Yinglu Li, Elizabeth M. Goldberg, Xiao Chen et al. · Molecular Cell · 2022 · 56 citations · Full text

, , +16

Serine starvation silences estrogen receptor signaling through histone hypoacetylation

Albert M. Li, Bo He, Dimitris Karagiannis et al. · Proceedings of the National Academy of Sciences · 2023 · 22 citations · Full text

, , +17

Metabolic reprogramming by histone deacetylase inhibition preferentially targets NRF2-activated tumors

Dimitris Karagiannis, Warren Wu, Albert P. Li et al. · Cell Reports · 2023 · 21 citations · Full text

, , +17

1–5 of 7